Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 7:26 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 817–840 of 8,685 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: Surgery, Hemoglobin
Interventions: Pulse CO-Oximetry Technology, Blood draw; Device · Other
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 621 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2024
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Knee Osteoarthritis
Interventions: Amniotic Suspension Allograft, Placebo; Biological · Drug
Lead sponsor: Organogenesis; Industry
Eligibility: 18 Years and older
Enrollment: 516 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 38
States / cities: Birmingham, Alabama • Mobile, Alabama • Glendale, Arizona + 30 more

Conditions: Achalasia
Interventions: POEM; Procedure
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years to 85 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2024
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Chronic Thromboembolic Pulmonary Hypertension, Acute Lung Injury
Interventions: Ventilation Strategy; Other
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Ulcerative Colitis
Interventions: Not listed
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 80 Years
Enrollment: 103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Ileus, Gastrointestinal Dysfunction
Interventions: Alvimopan; Drug
Lead sponsor: Scott Steele; Other
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Venous Ulcer
Interventions: Apligraf, Standard of Care Dressing Group; Device · Other
Lead sponsor: Organogenesis; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Radiodermatitis
Interventions: Difinsa53, Aquaphor; Drug
Lead sponsor: ProTechSure Scientific, Inc.; Industry
Eligibility: Female only
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Fort Collins, Colorado

Conditions: Hypertension, Diabetes Type 2
Interventions: Aliskiren, Hydrochlorothiazide; Drug
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Depression During Pregnancy
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Wounds, Compartment Syndromes
Interventions: Wound Care -Wound Vacuum Assisted Closure (VAC), Wound Care - Wet to Dry Dressing Changes; Device · Procedure
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 99 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Arthroplasty, Replacement, Hip
Interventions: Rejuvenate Modular Hip; Device
Lead sponsor: Stryker Orthopaedics; Industry
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2022
U.S. locations: 3
States / cities: Dearborn, Michigan • Sartell, Minnesota • Tulsa, Oklahoma

Conditions: Constipation, Impaction, and Bowel Obstruction, Unspecified Adult Solid Tumor, Protocol Specific
Interventions: therapeutic conventional surgery, gastrointestinal complications management/prevention, quality-of-life assessment; Procedure · Other
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: 18 Years and older
Enrollment: 221 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 34
States / cities: Phoenix, Arizona • Tucson, Arizona • Little Rock, Arkansas + 26 more

Conditions: Renal Allograft Recipients
Interventions: Belatacept, Tacrolimus, Cyclosporine A, Mycophenolate Mofetil, Enteric Coated Mycophenolate Sodium, Corticosteroids; Biological · Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 12 Years to 17 Years
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2034
U.S. locations: 15
States / cities: Birmingham, Alabama • Los Angeles, California • Washington D.C., District of Columbia + 12 more

Conditions: Gastrointestinal Neoplasms
Interventions: Traction Device; Device
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Chlamydia Infections, Gonorrhea, Trichomonas Infections
Interventions: APTIMA® Trichomonas vaginalis & APTIMA® COMBO 2® Assays; Device
Lead sponsor: Gen-Probe, Incorporated; Industry
Eligibility: 16 Years and older · Female only
Enrollment: 1,336 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2013
U.S. locations: 14
States / cities: Birmingham, Alabama • San Diego, California • North Miami, Florida + 11 more

Conditions: Pain
Interventions: Non-visual immersive technology-based audio biofeedback intervention, Control (No non-visual immersive technology-based audio biofeedback); Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Heart Failure
Interventions: Strength Training for Frailty; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Colorectal Cancer Screening
Interventions: MyCRCS+Prefs, MyCRCS+Prefs+Barriers; Behavioral
Lead sponsor: Temple University; Other
Eligibility: 50 Years to 75 Years
Enrollment: 683 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2020
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania • Richmond, Virginia

Conditions: Coronary Disease
Interventions: placebo, dabigatran etexilate; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 1,878 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 1
States / cities: Clearwater, Florida

Conditions: Endometrial Cancer
Interventions: Lymphoseek, Single Photon Emission Computed Tomography (SPECT), Indocyanine Green (ICG), Neoprobe Gamma Detection System NPB11L(Model1102); Drug · Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Stanford, California

Conditions: Kidney Stone
Interventions: Norco 5milligram-325milligram Tablet, Ibuprofen 400 MILLIGRAM in 1 TABLET ORAL TABLET, FILM COATED; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Venous Thromboembolism
Interventions: Not listed
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 3 Months to 12 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 10
States / cities: La Jolla, California • San Diego, California • New Haven, Connecticut + 7 more

Conditions: Indication for Peripheral Intravenous Catheterization
Interventions: SHERLOCK 3CG™ Tip Confirmation System with MODUS Software; Device
Lead sponsor: C. R. Bard; Industry
Eligibility: 21 Years and older
Enrollment: 182 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 2
States / cities: Colorado Springs, Colorado • Montgomery, Ohio

Search by objective public record fields.

Accuracy of Pulse CO-Oximetry Technology in Characterizing Noninvasive SpHb

Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee

Per-Oral Endoscopic Myotomy for Esophageal Swallowing Disorders

Lung Protective Ventilation in Pulmonary Thromboendarterectomy (PTE) Patients

Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center Study

Alvimopan as a Rescue Treatment of Postoperative Ileus

A Post Marketing Study of Apligraf in Non-healing Wounds of Subjects With Venous Leg Ulcers

Topical Use of Difinsa53™ to Prevent Radiation Dermatitis

Evaluating the Effect of Aliskiren Versus HCTZ on Coronary Flow Reserve in Hypertensive Type II Diabetics

The Association Between Gut Microbiota Diversity and Postpartum Depression

Study to Determine the Utility of Wound Vacuum Assisted Closure (VAC) Compared to Conventional Saline Dressing Changes

Rejuvenate Modular Outcomes Study

S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction

A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications

Feasibility and Prospective Study of a Dynamic Traction Device for Use During ESD

Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays

IceBath: NOICE vs Nothing

Cardiac Rehab for Advanced Heart Failure-LVAD Candidates

An Interactive Preventive Health Record to Increase Colorectal Cancer Screening

RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome

Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer

Opioid Free Management After Ureteroscopy

A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot

Study to Assess Electrocardiogram Waveforms Produced Through the Utilization of the Sherlock 3CG™ Tip Confirmation System